Attached files
| file | filename |
|---|---|
| 10-Q - Hubei Minkang Pharmaceutical Ltd. | v211021_10q.htm |
| EX-32.1 - Hubei Minkang Pharmaceutical Ltd. | v211021_ex32-1.htm |
| EX-31.2 - Hubei Minkang Pharmaceutical Ltd. | v211021_ex31-2.htm |
| EX-31.1 - Hubei Minkang Pharmaceutical Ltd. | v211021_ex31-1.htm |
Exhibit
32.2
CERTIFICATION
PURSUANT TO
18 U.S.C.
SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Quarterly Report on Form 10-Q for the quarter ended December
31, 2010 of Hubei Minkang Pharmaceutical Ltd., a Nevada corporation (the
“Company”), as filed with the Securities and Exchange Commission on the date
hereof (the “Report”), I, Hsien Loong Wong, President, CEO, CFO, Secretary,
Treasurer and a director of the Company certify, pursuant to 18 U.S.C. Section
1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:
|
|
1.
|
The
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934, as amended;
and
|
|
|
2.
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
|
Dated:
February 11, 2011
|
/s/ Hsien Loong Wong
|
|
Hsien
Loong Wong, President, CEO, CFO, Secretary,
|
|
|
Treasurer
and a Director
|
|
|
(Principal
Financial Officer)
|